Azacitidine in combination with HAG for newly diagnosed and relapsed/refractory AML: a prospective cohort study. Pan H, Gao Z, Lian Y, Zhao J, et al. Ann Hematol 2025;104:1597-1604.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Pan H, Gao Z, Lian Y, Zhao J, et al. Azacitidine in combination with HAG for newly diagnosed and relapsed/refractory AML: a prospective cohort study. Ann Hematol 2025;104:1597-1604.
PMID: 40014083